Edition:
United States

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

592.15INR
6:24am EDT
Change (% chg)

Rs-0.65 (-0.11%)
Prev Close
Rs592.80
Open
Rs592.00
Day's High
Rs598.55
Day's Low
Rs584.70
Volume
35,599
Avg. Vol
59,332
52-wk High
Rs699.00
52-wk Low
Rs514.50

ALEM.NS

Chart for ALEM.NS

About

Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal,... (more)

Overall

Beta: 0.49
Market Cap(Mil.): Rs111,752.20
Shares Outstanding(Mil.): 188.52
Dividend: 4.00
Yield (%): 0.67

Financials

  ALEM.NS Industry Sector
P/E (TTM): 27.88 29.37 30.15
EPS (TTM): 21.27 -- --
ROI: -- 13.51 13.05
ROE: -- 14.42 14.20

BRIEF-Alembic Pharmaceuticals says launch of depression treating drug by Breckenridge Pharma

* Says launch of Desvenlafaxine Succinate extended release tablets by partner Breckenridge Pharma

Mar 03 2017

BRIEF-Alembic Pharmaceuticals Dec-qtr consol profit falls

* Consol Dec quarter net profit 865.5 million rupees versus 2.69 billion rupees year ago

Jan 25 2017

BRIEF-Alembic Pharmaceuticals receives ANDA approval for drug to treat hypertension

* Alembic Pharmaceuticals Limited receives ANDA approval for Telmisartan and Amlodipine tablets Source text: [Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 18, 2016, title " Alembic Pharmaceuticals Limited receives ANDA Approval for Telmisartan and Amlodipine Tablets"] Further company coverage:

Nov 18 2016

BRIEF-Alembic Pharma Sept-qtr consol profit falls

* Sept quarter consol net profit 1.20 billion rupees versus 2.89 billion rupees year ago

Oct 25 2016

BRIEF-Alembic Pharma's Panelav facility gets EIR from USFDA for March inspection

* Formulation facility located at Panelav has received EIR from US FDA for the inspection carried out by them in March, 2016. Source text: http://bit.ly/2cRosD5 Further company coverage:

Oct 05 2016

More From Around the Web

Earnings vs. Estimates